Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD7648 Monotherapy and Combination in Advanced Malignancies
NCT03907969Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of AZD-7648 in solid tumor (advanced stage), sponsored by AstraZeneca. Started Oct 2019; status: completed.
02
Drugs
AZD-7648
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT03907969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03907969.